China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
–Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
— Phase I clinical studies indicated that sebum production was inhibited by ASC40 in a dose-dependent fashion
— Acne is the eighth most prevalent…
